Hims and Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its ...
PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...
Pfizer Inc. and Novo Nordisk A/S boosted their bids for Metsera Inc. as the ongoing battle for the obesity startup intensified ahead of a court battle slated for Tuesday, underscoring the surging ...
Weight loss drugs are set to become a disproportionate share of Lilly's business.
45mon MSN
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback